Echocardiographic parameters predicting acute hemodynamically significant mitral regurgitation during transfemoral transcatheter aortic valve replacement

Alteration in mitral valve morphology resulting from retrograde stiff wire entanglement sometimes causes hemodynamically significant acute mitral regurgitation (MR) during transfemoral transcatheter aortic valve replacement (TAVR). Little is known about the echocardiographic parameters related to hemodynamically significant acute MR.

[1]  Guson Kang,et al.  Expanding transcatheter aortic valve replacement into uncharted indications , 2018, The Korean journal of internal medicine.

[2]  A. Zaman,et al.  Local Versus General Anesthesia in Transcatheter Aortic Valve Replacement. , 2016, The American journal of cardiology.

[3]  M. Mack,et al.  Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. , 2016, The New England journal of medicine.

[4]  L. W. Andersen,et al.  Transcatheter Versus Surgical Aortic Valve Replacement in Patients With Severe Aortic Valve Stenosis: 1-Year Results From the All-Comers NOTION Randomized Clinical Trial. , 2015, Journal of the American College of Cardiology.

[5]  Victor Mor-Avi,et al.  Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.

[6]  E. Tuzcu,et al.  Echocardiographic imaging of procedural complications during balloon-expandable transcatheter aortic valve replacement. , 2015, JACC. Cardiovascular imaging.

[7]  P. Leprince,et al.  Clinical Outcomes and Safety of Transfemoral Aortic Valve Implantation Under General Versus Local Anesthesia: Subanalysis of the French Aortic National CoreValve and Edwards 2 Registry , 2014, Circulation. Cardiovascular interventions.

[8]  Thoralf M Sundt,et al.  2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Journal of the American College of Cardiology.

[9]  Thoralf M Sundt,et al.  2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. , 2014, Circulation.

[10]  R. Siegel,et al.  Effect of Transcatheter Aortic Valve Replacement on the Mitral Valve Apparatus and Mitral Regurgitation: Real-Time Three-Dimensional Transesophageal Echocardiography Study , 2014, Circulation. Cardiovascular imaging.

[11]  H. Schaff,et al.  Mechanisms of functional mitral regurgitation in ischemic cardiomyopathy determined by transesophageal echocardiography (from the Surgical Treatment for Ischemic Heart Failure Trial). , 2013, The American journal of cardiology.

[12]  J. Zamorano,et al.  Prosthesis/annulus discongruence assessed by three-dimensional transoesophageal echocardiography: a predictor of significant paravalvular aortic regurgitation after transcatheter aortic valve implantation. , 2012, European heart journal cardiovascular Imaging.

[13]  Sanjay Kaul,et al.  2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. , 2012, Journal of the American College of Cardiology.

[14]  Stuart J Pocock,et al.  Transcatheter versus surgical aortic-valve replacement in high-risk patients. , 2011, The New England journal of medicine.

[15]  Victor Mor-Avi,et al.  Characterization of Degenerative Mitral Valve Disease Using Morphologic Analysis of Real-Time Three-Dimensional Echocardiographic Images: Objective Insight Into Complexity and Planning of Mitral Valve Repair , 2011, Circulation. Cardiovascular imaging.

[16]  Jean-Louis Vanoverschelde,et al.  EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. , 2011, European heart journal.

[17]  S. Pocock,et al.  Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. , 2010, The New England journal of medicine.

[18]  Susheel Kodali,et al.  ranscatheter Aortic Valve Implantation eview of the Nature , Management , and Avoidance of Procedural Complications , 2022 .

[19]  Judith S. Hochman,et al.  Cardiogenic Shock: Current Concepts and Improving Outcomes , 2008, Circulation.

[20]  Hirofumi Makino,et al.  Modification of the Modification of Diet in Renal Disease (MDRD) Study equation for Japan. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  E. Schwammenthal,et al.  Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. , 2005, Circulation.

[22]  W John Boscardin,et al.  Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. , 2005, JAMA.

[23]  Jun Kwan,et al.  Geometric Differences of the Mitral Apparatus Between Ischemic and Dilated Cardiomyopathy With Significant Mitral Regurgitation: Real-Time Three-Dimensional Echocardiography Study , 2002, Circulation.

[24]  E. Schwammenthal,et al.  Mechanism of dynamic regurgitant orifice area variation in functional mitral regurgitation: physiologic insights from the proximal flow convergence technique. , 1999, Journal of the American College of Cardiology.

[25]  I. Palacios,et al.  Percutaneous balloon dilatation of the mitral valve: an analysis of echocardiographic variables related to outcome and the mechanism of dilatation. , 1988, British heart journal.